Source:http://linkedlifedata.com/resource/pubmed/id/10938594
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2000-11-24
|
pubmed:abstractText |
Twenty-three patients with HBe antigen-positive chronic hepatitis B were treated with capitalite first letters Maruyama (SSM). HBe antigen turned negative in 15 patients. The levels of various cytokines in pre- and post-treatment frozen serum samples from six patients whose HBe antigen turned negative and from five whose HBe antigen did not were examined. Reduction of serum interleukin (IL) -10 level to below 20 pg/ml was observed after SSM treatment in four of the six patients whose HBe antigen turned negative. SSM was found to stimulate the production of interferon (IFN) -gamma in peripheral blood cells from two healthy volunteers. This stimulatory effect was confirmed in 12 out of 24 healthy volunteers. SSM augmented the production of IFN-gamma in eight out of 10 patients with chronic hepatitis B and nine of 10 with hepatitis C. These results demonstrate for the first time that SSM stimulates the production of IFN-gamma in human peripheral blood cells and also suggest that treatment of HBe antigen-positive chronic hepatitis B patients with SSM leads to the clearance of HBe antigen and normalization of serum aspartate aminotransferase levels through inhibition of IL-10 and stimulation of IFN-gamma.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Aspartate Aminotransferases,
http://linkedlifedata.com/resource/pubmed/chemical/Hepatitis B e Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-10,
http://linkedlifedata.com/resource/pubmed/chemical/Lipids,
http://linkedlifedata.com/resource/pubmed/chemical/Mannans,
http://linkedlifedata.com/resource/pubmed/chemical/specific substance maruyama
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1345-4676
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
67
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
261-6
|
pubmed:dateRevised |
2011-8-1
|
pubmed:meshHeading |
pubmed-meshheading:10938594-Adult,
pubmed-meshheading:10938594-Aspartate Aminotransferases,
pubmed-meshheading:10938594-Blood Cells,
pubmed-meshheading:10938594-Female,
pubmed-meshheading:10938594-Hepatitis B, Chronic,
pubmed-meshheading:10938594-Hepatitis B e Antigens,
pubmed-meshheading:10938594-Humans,
pubmed-meshheading:10938594-Interferon-gamma,
pubmed-meshheading:10938594-Interleukin-10,
pubmed-meshheading:10938594-Lipids,
pubmed-meshheading:10938594-Male,
pubmed-meshheading:10938594-Mannans,
pubmed-meshheading:10938594-Middle Aged,
pubmed-meshheading:10938594-Stimulation, Chemical
|
pubmed:year |
2000
|
pubmed:articleTitle |
Effects of SSM (specific substance maruyama) on HBe antigen-positive chronic hepatitis B -clinical efficacy and modulation of cytokines.
|
pubmed:affiliation |
The First Department of Internal Medicine, Nippon Medical School.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|